Cargando…
A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy
BACKGROUND: Advances in cancer biology are increasingly dependent on integration of heterogeneous datasets. Large-scale efforts have systematically mapped many aspects of cancer cell biology; however, it remains challenging for individual scientists to effectively integrate and understand this data....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524992/ https://www.ncbi.nlm.nih.gov/pubmed/34663427 http://dx.doi.org/10.1186/s13073-021-00987-8 |
_version_ | 1784585586132123648 |
---|---|
author | Yogodzinski, Christopher Arab, Abolfazl Pritchard, Justin R. Goodarzi, Hani Gilbert, Luke A. |
author_facet | Yogodzinski, Christopher Arab, Abolfazl Pritchard, Justin R. Goodarzi, Hani Gilbert, Luke A. |
author_sort | Yogodzinski, Christopher |
collection | PubMed |
description | BACKGROUND: Advances in cancer biology are increasingly dependent on integration of heterogeneous datasets. Large-scale efforts have systematically mapped many aspects of cancer cell biology; however, it remains challenging for individual scientists to effectively integrate and understand this data. RESULTS: We have developed a new data retrieval and indexing framework that allows us to integrate publicly available data from different sources and to combine publicly available data with new or bespoke datasets. Our approach, which we have named the cancer data integrator (CanDI), is straightforward to implement, is well documented, and is continuously updated which should enable individual users to take full advantage of efforts to map cancer cell biology. We show that CanDI empowered testable hypotheses of new synthetic lethal gene pairs, genes associated with sex disparity, and immunotherapy targets in cancer. CONCLUSIONS: CanDI provides a flexible approach for large-scale data integration in cancer research enabling rapid generation of hypotheses. The CanDI data integrator is available at https://github.com/GilbertLabUCSF/CanDI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-021-00987-8. |
format | Online Article Text |
id | pubmed-8524992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85249922021-10-22 A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy Yogodzinski, Christopher Arab, Abolfazl Pritchard, Justin R. Goodarzi, Hani Gilbert, Luke A. Genome Med Software BACKGROUND: Advances in cancer biology are increasingly dependent on integration of heterogeneous datasets. Large-scale efforts have systematically mapped many aspects of cancer cell biology; however, it remains challenging for individual scientists to effectively integrate and understand this data. RESULTS: We have developed a new data retrieval and indexing framework that allows us to integrate publicly available data from different sources and to combine publicly available data with new or bespoke datasets. Our approach, which we have named the cancer data integrator (CanDI), is straightforward to implement, is well documented, and is continuously updated which should enable individual users to take full advantage of efforts to map cancer cell biology. We show that CanDI empowered testable hypotheses of new synthetic lethal gene pairs, genes associated with sex disparity, and immunotherapy targets in cancer. CONCLUSIONS: CanDI provides a flexible approach for large-scale data integration in cancer research enabling rapid generation of hypotheses. The CanDI data integrator is available at https://github.com/GilbertLabUCSF/CanDI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-021-00987-8. BioMed Central 2021-10-18 /pmc/articles/PMC8524992/ /pubmed/34663427 http://dx.doi.org/10.1186/s13073-021-00987-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Software Yogodzinski, Christopher Arab, Abolfazl Pritchard, Justin R. Goodarzi, Hani Gilbert, Luke A. A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy |
title | A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy |
title_full | A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy |
title_fullStr | A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy |
title_full_unstemmed | A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy |
title_short | A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy |
title_sort | global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy |
topic | Software |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524992/ https://www.ncbi.nlm.nih.gov/pubmed/34663427 http://dx.doi.org/10.1186/s13073-021-00987-8 |
work_keys_str_mv | AT yogodzinskichristopher aglobalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy AT arababolfazl aglobalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy AT pritchardjustinr aglobalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy AT goodarzihani aglobalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy AT gilbertlukea aglobalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy AT yogodzinskichristopher globalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy AT arababolfazl globalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy AT pritchardjustinr globalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy AT goodarzihani globalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy AT gilbertlukea globalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy |